Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naïve Individuals in Nigeria.

Jumare J, Akolo C, Ndembi N, Bwala S, Alabi P, Okwuasaba K, Adebiyi R, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002320. [Epub ahead of print]

PMID:
32084055
2.

Demographically-adjusted norms for the Grooved Pegboard and Finger Tapping tests in Spanish-speaking adults: Results from the Neuropsychological Norms for the U.S.-Mexico Border Region in Spanish (NP-NUMBRS) Project.

Heaton A, Gooding A, Cherner M, Umlauf A, Franklin DR, Rivera Mindt M, Suárez P, Artiola I Fortuni L, Heaton RK, Marquine MJ.

Clin Neuropsychol. 2020 Feb 20:1-23. doi: 10.1080/13854046.2020.1713400. [Epub ahead of print]

PMID:
32077791
3.

Demographically-adjusted norms for the paced auditory serial addition test and letter number sequencing test in Spanish-speaking adults: Results from the neuropsychological norms for the U.S.-Mexico border region in Spanish (NP-NUMBRS) Project.

Gooding A, Seider T, Marquine M, Suárez P, Umlauf A, Rivera Mindt M, Heaton RK, Artiola I Fortuni L, Cherner M.

Clin Neuropsychol. 2020 Feb 11:1-15. doi: 10.1080/13854046.2019.1711199. [Epub ahead of print]

PMID:
32043418
4.

Genetic variation in alcohol dehydrogenase is associated with neurocognition in men with HIV and history of alcohol use disorder: preliminary findings.

Saloner R, Paolillo EW, Kohli M, Murray SS, Moore DJ, Grant I, Cherner M.

J Neurovirol. 2020 Jan 13. doi: 10.1007/s13365-019-00825-z. [Epub ahead of print]

PMID:
31933193
5.

Demographically-adjusted norms for the WAIS-R Block Design and Arithmetic subtests: Results from the Neuropsychological Norms for the US-Mexico Border Region in Spanish (NP-NUMBRS) project.

Scott TM, Morlett Paredes A, Taylor MJ, Umlauf A, Artiola I Fortuny L, Heaton RK, Cherner M, Marquine MJ, Rivera Mindt M.

Clin Neuropsychol. 2020 Jan 13:1-14. doi: 10.1080/13854046.2019.1707285. [Epub ahead of print]

PMID:
31928314
6.

Demographically adjusted normative data for the Halstead category test in a Spanish-speaking adult population: Results from the Neuropsychological Norms for the U.S.-Mexico Border Region in Spanish (NP-NUMBRS).

Morlett Paredes A, Carrasco J, Kamalyan L, Cherner M, Umlauf A, Rivera Mindt M, Suarez P, Artiola I Fortuny L, Franklin D, Heaton RK, Marquine MJ.

Clin Neuropsychol. 2020 Jan 8:1-18. doi: 10.1080/13854046.2019.1709660. [Epub ahead of print]

PMID:
31913746
7.

Demographically adjusted normative data for the Wisconsin Card Sorting Test-64 item: Results from the Neuropsychological Norms for the U.S.-Mexico Border Region in Spanish (NP-NUMBRS) project.

Marquine MJ, Yassai-Gonzalez D, Perez-Tejada A, Umlauf A, Kamalyan L, Morlett Paredes A, Suarez P, Rivera Mindt M, Franklin D, Artiola I Fortuny L, Cherner M, Heaton RK.

Clin Neuropsychol. 2020 Jan 3:1-17. doi: 10.1080/13854046.2019.1703042. [Epub ahead of print]

PMID:
31900055
8.

Neurocognitive impairment in Spanish-speaking Latinos living with HIV in the US: Application of the neuropsychological norms for the US-Mexico border region in Spanish (NP-NUMBRS).

Kamalyan L, Hussain MA, Diaz MM, Umlauf A, Franklin DR, Cherner M, Rivera Mindt M, Artiola I Fortuny L, Grant I, Heaton RK, Marquine MJ.

Clin Neuropsychol. 2019 Dec 17:1-20. doi: 10.1080/13854046.2019.1701084. [Epub ahead of print]

PMID:
31847711
9.

Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.

Saloner R, Grelotti DJ, Tyree G, Sundermann EE, Ma Q, Letendre S, Heaton RK, Cherner M.

J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):475-482. doi: 10.1097/QAI.0000000000002183.

PMID:
31714426
10.

Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met/met genotype in methamphetamine-related executive dysfunction.

Cherner M, Watson CW, Saloner R, Halpin LE, Minassian A, Murray SS, Vaida F, Bousman C, Everall I; TMARC Group.

Addict Behav. 2019 Nov;98:106023. doi: 10.1016/j.addbeh.2019.06.012. Epub 2019 Jun 12.

PMID:
31301644
11.

Neurocognitive impairment is worse in HIV/HCV-coinfected individuals with liver dysfunction.

Barokar J, McCutchan A, Deutsch R, Tang B, Cherner M, Bharti AR.

J Neurovirol. 2019 Dec;25(6):792-799. doi: 10.1007/s13365-019-00767-6. Epub 2019 Jul 7.

PMID:
31281947
12.

Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Saloner R, Paolillo EW, Umlauf A, Moore DJ, Heaton RK, Grant I, Cherner M; TMARC Group.

J Int Neuropsychol Soc. 2019 Sep;25(8):787-799. doi: 10.1017/S1355617719000493. Epub 2019 Jun 10.

13.

COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk of Neurocognitive Impairment in Men Living With HIV.

Saloner R, Marquine MJ, Sundermann EE, Hong S, McCutchan JA, Ellis RJ, Heaton RK, Grant I, Cherner M.

J Acquir Immune Defic Syndr. 2019 Aug 15;81(5):e148-e157. doi: 10.1097/QAI.0000000000002083.

PMID:
31107306
14.

Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume.

MacDuffie KE, Brown GG, McKenna BS, Liu TT, Meloy MJ, Tawa B, Archibald S, Fennema-Notestine C, Atkinson JH Jr, Ellis RJ, Letendre SL, Hesselink JR, Cherner M, Grant I; TMARC Group.

Neuroimage Clin. 2018;20:1044-1052. doi: 10.1016/j.nicl.2018.09.034. Epub 2018 Oct 7.

15.

Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Ndembi N, Aliyu A, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

J Neurovirol. 2018 Dec;24(6):712-719. doi: 10.1007/s13365-018-0667-8. Epub 2018 Aug 30.

16.

Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.

de Almeida SM, de Pereira AP, Pedroso MLA, Ribeiro CE, Rotta I, Tang B, Umlauf A, Franklin D, Saloner RG, Batista MGR, Letendre S, Heaton RK, Ellis RJ, Cherner M; HNRC Group.

J Neurovirol. 2018 Jun;24(3):339-349. doi: 10.1007/s13365-018-0617-5. Epub 2018 Mar 7.

17.

Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.

Jumare J, Ndembi N, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

Clin Infect Dis. 2018 Apr 17;66(9):1448-1453. doi: 10.1093/cid/cix1019.

18.

Associations between neurocognitive functioning and social and occupational resilience among South African women exposed to childhood trauma.

Denckla CA, Consedine NS, Spies G, Cherner M, Henderson DC, Koenen KC, Seedat S.

Eur J Psychotraumatol. 2017 Nov 2;8(1):1394146. doi: 10.1080/20008198.2017.1394146. eCollection 2017.

19.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

20.

Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.

Jumare J, Sunshine S, Ahmed H, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Umlauf A, Cherner M, Abimiku A, Charurat M, Li JZ, Blattner WA, Royal W 3rd.

J Neurovirol. 2017 Jun;23(3):474-482. doi: 10.1007/s13365-017-0520-5. Epub 2017 Feb 27.

21.

Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender.

Kanmogne GD, Qiu F, Ntone FE, Fonsah JY, Njamnshi DM, Kuate CT, Doh RF, Kengne AM, Tagny CT, Nchindap E, Kenmogne L, Mbanya D, Cherner M, Heaton RK, Njamnshi AK.

PLoS One. 2017 Feb 23;12(2):e0171956. doi: 10.1371/journal.pone.0171956. eCollection 2017.

22.

Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.

de Almeida SM, Kamat R, Cherner M, Umlauf A, Ribeiro CE, de Pereira AP, Franklin D, Heaton RK, Ellis RJ.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):332-338. doi: 10.1097/QAI.0000000000001224. Erratum in: J Acquir Immune Defic Syndr. 2017 Oct 1;76(2):e64.

23.

Latent Toxoplasma Infection and Higher Toxoplasma gondii Immunoglobulin G Levels Are Associated With Worse Neurocognitive Functioning in HIV-Infected Adults.

Bharti AR, McCutchan A, Deutsch R, Smith DM, Ellis RJ, Cherner M, Woods SP, Heaton RK, Grant I, Letendre SL.

Clin Infect Dis. 2016 Dec 15;63(12):1655-1660. Epub 2016 Oct 28.

24.

Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil.

de Almeida SM, Barbosa FJ, Kamat R, de Pereira AP, Raboni SM, Rotta I, Ribeiro CE, Cherner M, Ellis RJ, Atkinson JH; HNRC Group.

J Neurovirol. 2016 Dec;22(6):789-798. Epub 2016 Jul 18.

25.

Changes in cognitive function in women with HIV infection and early life stress.

Spies G, Fennema-Notestine C, Cherner M, Seedat S.

AIDS Care. 2017 Jan;29(1):14-23. Epub 2016 Jul 11.

26.

Fibroblast growth factors 1 and 2 in cerebrospinal fluid are associated with HIV disease, methamphetamine use, and neurocognitive functioning.

Bharti AR, Woods SP, Ellis RJ, Cherner M, Rosario D, Potter M, Heaton RK, Everall IP, Masliah E, Grant I, Letendre SL.

HIV AIDS (Auckl). 2016 Apr 29;8:93-9. doi: 10.2147/HIV.S93306. eCollection 2016.

27.

The impact of age, HIV serostatus and seroconversion on methamphetamine use.

Montoya JL, Cattie J, Morgan E, Woods SP, Cherner M, Moore DJ, Atkinson JH, Grant I; Translational Methamphetamine Aids Research Center (TMARC) Group.

Am J Drug Alcohol Abuse. 2016 Mar;42(2):168-77. doi: 10.3109/00952990.2015.1114625. Epub 2016 Feb 2.

28.

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.

Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA.

PLoS One. 2016 Feb 1;11(2):e0147182. doi: 10.1371/journal.pone.0147182. eCollection 2016.

29.

The impact of ethnicity/race on the association between the Veterans Aging Cohort Study (VACS) Index and neurocognitive function among HIV-infected persons.

Marquine MJ, Sakamoto M, Dufour C, Rooney A, Fazeli P, Umlauf A, Gouaux B, Franklin D, Ellis R, Letendre S, Cherner M, Heaton RK, Grant I, Moore DJ; HNRP Group.

J Neurovirol. 2016 Aug;22(4):442-54. doi: 10.1007/s13365-015-0411-6. Epub 2015 Dec 17.

30.

Cell-free mitochondrial DNA in CSF is associated with early viral rebound, inflammation, and severity of neurocognitive deficits in HIV infection.

Pérez-Santiago J, Schrier RD, de Oliveira MF, Gianella S, Var SR, Day TR, Ramirez-Gaona M, Suben JD, Murrell B, Massanella M, Cherner M, Smith DM, Ellis RJ, Letendre SL, Mehta SR.

J Neurovirol. 2016 Apr;22(2):191-200. doi: 10.1007/s13365-015-0384-5. Epub 2015 Oct 1.

31.

Effects of HIV and childhood trauma on brain morphometry and neurocognitive function.

Spies G, Ahmed-Leitao F, Fennema-Notestine C, Cherner M, Seedat S.

J Neurovirol. 2016 Apr;22(2):149-58. doi: 10.1007/s13365-015-0379-2. Epub 2015 Sep 30.

32.

Ethical and methodological considerations on conducting clinical research in poor and low-income countries: Viewpoint of the authors of the BEST TRIP ICP randomized trial in Latin America.

Chesnut RM, Temkin N, Dikmen S, Rondina C, Videtta W, Lujan S, Petroni G, Pridgeon J, Barber J, Machamer J, Chaddock K, Celix JM, Cherner M, Hendrix T.

Surg Neurol Int. 2015 Jul 2;6:116. doi: 10.4103/2152-7806.159841. eCollection 2015. No abstract available.

33.

SNP genotyping using TaqMan technology: the CYP2D6*17 assay conundrum.

Gaedigk A, Freeman N, Hartshorne T, Riffel AK, Irwin D, Bishop JR, Stein MA, Newcorn JH, Jaime LK, Cherner M, Leeder JS.

Sci Rep. 2015 Mar 19;5:9257. doi: 10.1038/srep09257.

34.

Telepsychiatry for Neurocognitive Testing in Older Rural Latino Adults.

Vahia IV, Ng B, Camacho A, Cardenas V, Cherner M, Depp CA, Palmer BW, Jeste DV, Agha Z.

Am J Geriatr Psychiatry. 2015 Jul;23(7):666-70. doi: 10.1016/j.jagp.2014.08.006. Epub 2014 Aug 20.

35.

Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatment.

Cattie JE, Letendre SL, Woods SP, Barakat F, Perry W, Cherner M, Umlauf A, Franklin D, Heaton RK, Hassanein T, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

J Neurovirol. 2014 Dec;20(6):561-70. doi: 10.1007/s13365-014-0265-3. Epub 2014 Oct 18.

36.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

37.

HIV and aging: effects on the central nervous system.

Cañizares S, Cherner M, Ellis RJ.

Semin Neurol. 2014 Feb;34(1):27-34. doi: 10.1055/s-0034-1372340. Epub 2014 Apr 8. Review.

38.

Second-language fluency predicts native language stroop effects: evidence from Spanish-English bilinguals.

Suarez PA, Gollan TH, Heaton R, Grant I, Cherner M; HNRC Group.

J Int Neuropsychol Soc. 2014 Mar;20(3):342-8. doi: 10.1017/S1355617714000058.

39.

HIV-associated distal neuropathic pain is associated with smaller total cerebral cortical gray matter.

Keltner JR, Fennema-Notestine C, Vaida F, Wang D, Franklin DR, Dworkin RH, Sanders C, McCutchan JA, Archibald SL, Miller DJ, Kesidis G, Cushman C, Kim SM, Abramson I, Taylor MJ, Theilmann RJ, Julaton MD, Notestine RJ, Corkran S, Cherner M, Duarte NA, Alexander T, Robinson-Papp J, Gelman BB, Simpson DM, Collier AC, Marra CM, Morgello S, Brown G, Grant I, Atkinson JH, Jernigan TL, Ellis RJ; CHARTER Group.

J Neurovirol. 2014 Jun;20(3):209-18. doi: 10.1007/s13365-014-0236-8. Epub 2014 Feb 19.

40.

Randomized trial of central nervous system-targeted antiretrovirals for HIV-associated neurocognitive disorder.

Ellis RJ, Letendre S, Vaida F, Haubrich R, Heaton RK, Sacktor N, Clifford DB, Best BM, May S, Umlauf A, Cherner M, Sanders C, Ballard C, Simpson DM, Jay C, McCutchan JA.

Clin Infect Dis. 2014 Apr;58(7):1015-22. doi: 10.1093/cid/cit921. Epub 2013 Dec 18.

41.

Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.

de Almeida SM, Ribeiro CE, de Pereira AP, Badiee J, Cherner M, Smith D, Maich I, Raboni SM, Rotta I, Barbosa FJ, Heaton RK, Umlauf A, Ellis RJ.

J Neurovirol. 2013 Dec;19(6):550-6. doi: 10.1007/s13365-013-0215-5. Epub 2013 Nov 26.

42.

Molecular and pathologic insights from latent HIV-1 infection in the human brain.

Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E.

Neurology. 2013 Apr 9;80(15):1415-23. doi: 10.1212/WNL.0b013e31828c2e9e. Epub 2013 Mar 13.

43.

Implications of apathy and depression for everyday functioning in HIV/AIDS in Brazil.

Kamat R, Morgan E, Marcotte TD, Badiee J, Maich I, Cherner M, de Almeida S, de Pereira AP, Ribeiro CE, Barbosa F, Atkinson JH, Ellis R; HNRP Group.

J Affect Disord. 2013 Sep 25;150(3):1069-75. doi: 10.1016/j.jad.2012.11.040. Epub 2012 Dec 11.

44.

A trial of intracranial-pressure monitoring in traumatic brain injury.

Chesnut RM, Temkin N, Carney N, Dikmen S, Rondina C, Videtta W, Petroni G, Lujan S, Pridgeon J, Barber J, Machamer J, Chaddock K, Celix JM, Cherner M, Hendrix T; Global Neurotrauma Research Group.

N Engl J Med. 2012 Dec 27;367(26):2471-81. doi: 10.1056/NEJMoa1207363. Epub 2012 Dec 12. Erratum in: N Engl J Med. 2013 Dec 19;369(25):2465.

45.

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers.

Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL.

AIDS. 2012 Nov 28;26(18):2327-35. doi: 10.1097/QAD.0b013e32835a117c.

46.

Traumatic brain injury in Latin America: lifespan analysis randomized control trial protocol*.

Chesnut RM, Temkin N, Carney N, Dikmen S, Pridgeon J, Barber J, Celix JM, Chaddock K, Cherner M, Hendrix T, Lujan S, Machamer J, Petroni G, Rondina C, Videtta W.

Neurosurgery. 2012 Dec;71(6):1055-63. doi: 10.1227/NEU.0b013e31827276b7.

47.

Neurocognitive deficits in HIV-infected women and victims of childhood trauma.

Spies G, Fennema-Notestine C, Archibald SL, Cherner M, Seedat S.

AIDS Care. 2012;24(9):1126-35. doi: 10.1080/09540121.2012.687813. Epub 2012 Jun 6.

48.

Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.

Royal W 3rd, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA.

J Neurovirol. 2012 Jun;18(3):191-9. doi: 10.1007/s13365-012-0097-y. Epub 2012 Apr 18. Erratum in: J Neurovirol. 2012 Oct;18(5):441. McCutchen, J Allen [corrected to McCutchan, J Allen].

49.

Intracranial pressure monitoring in severe traumatic brain injury in latin america: process and methods for a multi-center randomized controlled trial.

Carney N, Lujan S, Dikmen S, Temkin N, Petroni G, Pridgeon J, Barber J, Machamer J, Cherner M, Chaddock K, Hendrix T, Rondina C, Videtta W, Celix JM, Chesnut R.

J Neurotrauma. 2012 Jul 20;29(11):2022-9. doi: 10.1089/neu.2011.2019. Epub 2012 May 15.

50.

Impact of childhood trauma on functionality and quality of life in HIV-infected women.

Troeman ZC, Spies G, Cherner M, Archibald SL, Fennema-Notestine C, Theilmann RJ, Spottiswoode B, Stein DJ, Seedat S.

Health Qual Life Outcomes. 2011 Sep 30;9:84. doi: 10.1186/1477-7525-9-84.

Supplemental Content

Loading ...
Support Center